‘Peace of mind to pharmacists and their patients’: Teva updates packaging across generics portfolio


Share post:

Teva UK has begun replacing its existing packaging with a new design which is “clearer and easier to read”.

The new look is “unique, recognizable and distinctive.” It “enhances safety and provides a recognizable and distinguishable pack range.”

One of the UK’s leading generics manufacturers, Teva UK supplies more than 500 generic pharmaceutical products to retail and hospital pharmacies.

The company says each product within the portfolio is distinguishable by color, ensuring no two different packs have the same drug and strength colors and with additional product information on the side of the pack and a simplified back, it makes it even easier to identify the correct product when dispensing and supports patients when taking their medication.

“Our medicines impact the lives of millions of people every day and our packaging is often the first touchpoint for our patients and our customers”, said Kim Innes, general manager of Teva UK and Ireland.

“We’ve updated our packaging with the dispensing process and patients in mind making packs clearer and easier to read, ensuring no two packs have the same drug and strength color, bringing peace of mind to pharmacists and their patients.”

In 2006, Teva introduced packaging designed with the end user in mind, making products on the shelf easier to distinguish and dispense. The new design, the company said, builds on this work and have been produced following extensive consultation with more than 4,000 healthcare professionals, patients and carers from around the UK and the rest of the world, as well as spending hundreds of hours engaging with our regulatory authorities.

Pharmacists can experience the pack and see the thinking behind our design changes using augmented reality by scanning a QR code which can be found across all related packaging launch materials.

The company added: “The new packaging will be applied across our whole generics portfolio, helping people understand our wider range of products and will be moved onto branded and OTC lines over the course of 2023.”


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...